Abstract:Viral hepatitis continues to be a serious global health concern, impacting millions of people, putting a strain on healthcare systems across the world, and causing significant morbidity and mortality. Traditional diagnostic, prognostic, and therapeutic procedures to address viral hepatitis are successful but have limits in accuracy, speed, and accessibility. Artificial intelligence (AI) advancement provides substantial opportunities to overcome these challenges. This study investigates the role of AI in revolutionizing viral hepatitis care, from early detection to therapy optimization and epidemiological surveillance. A comprehensive literature review was conducted using predefined keywords in the Nature, PLOS ONE, PubMed, Frontiers, Wiley Online Library, BMC, Taylor & Francis, Springer, ScienceDirect, MDPI, IEEE Xplore Digital Library, and Google Scholar databases. Peer-reviewed publications written in English between January 2019 and August 2024 were examined. The data of the selected research papers were synthesized and analyzed using thematic and narrative analysis techniques. The use of AI-driven algorithms in viral hepatitis control involves many significant aspects. AI improves diagnostic accuracy by integrating machine learning (ML) models with serological, genomic, and imaging data. It enables tailored treatment plans by assessing patient-specific characteristics and predicting therapy responses. AI-powered technologies aid in epidemiological modeling, and AI-powered systems effectively track treatment adherence, identify medication resistance, and control complications associated with chronic hepatitis infections. It is vital in identifying new antiviral medicines and vaccines, speeding the development pipeline through high-throughput screening and predictive modeling. Despite its transformational promise, using AI in viral hepatitis care presents various challenges, including data privacy concerns, the necessity for extensive and varied datasets, and the possibility of algorithmic biases. Ethical considerations, legal frameworks, and multidisciplinary collaboration are required to resolve these issues and ensure AI technology’s safe and successful use in clinical practice. Exploiting the full AI’s potential for viral hepatitis management provides unparalleled prospects to improve patient outcomes, optimize public health policies, and, eventually, and alleviate the disease’s negative impact worldwide. This study seeks to provide academics, medics, and policymakers with the fundamental knowledge they need to harness AI’s potential in the fight against viral hepatitis.

Research Trends, Gaps, and Prospects for Viral Hepatitis in Southeast Asia: A Bibliometric Analysis

Infectious disease research in the Association of Southeast Asian Nations region: a scientometric analysis

Changing trends in viral hepatitis mortality in East and Southeast Asia between 1987 and 2015 and its prediction until 2030

Trends in Hepatitis A Research Indexed in the Web of Science: a Bibliometric Analysis over the Period from 1985 to 2019

Realm of hepatitis E: Challenges and opportunities.

Burden and Trends of Acute Viral Hepatitis in Asia from 1990 to 2019

Early Epidemiological Features and Trends of the COVID-19 Outbreak in Southeast Asia: a Population-Level Observational Study

Hepatitis B: Overview of the Burden of Disease in the Asia‐Pacific Region

Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030

Systematic review and meta-analysis of hepatitis E seroprevalence in Southeast Asia: a comprehensive assessment of epidemiological patterns

Strengthening Virology Research in the Association of Southeast Asian Nations: Preparing for Future Pandemics.

Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study

Epidemiology, Diagnosis, Vaccines, and Bibliometric Analysis of the 100 Top-Cited Studies on Hepatitis E Virus

Prevalence of hepatitis A and E viruses in wastewater in Asian countries

Emerging and re-emerging zoonotic viral diseases in Southeast Asia: One Health challenge

Unmet needs in occupational health: prevention and management of viral hepatitis in healthcare workers in Ho Chi Minh City, Vietnam: a mixed-methods study

A Recent Prevalence of Hepatitis B Virus (HBV) Genotypes and Subtypes in Asia: A Systematic Review and Meta-Analysis

Harnessing the Potential of Artificial Intelligence in Managing Viral Hepatitis

Ten-years trend of dengue research in Indonesia and South-east Asian countries: a bibliometric analysis

Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies